drugset / Trial / NCT01018342

Fed Study of Mylan Nitrofurantoin Monohydrate/Macrocrystals Capsules 100 mg and Macrobid® Capsules 100 mg

NCT01018342

Phase 1 Completed 80 enrolled Mylan Pharmaceuticals Inc
RandomizedCrossoverOpen-labelOther

Summary

The objective of this study was to investigate the bioequivalence of Mylan nitrofurantoin monohydrate/macrocrystals capsules to Procter \& Gamble Macrobid® capsules following a single, oral 100 mg (1 x 100 mg) dose under fed conditions.

Timeline

Start
2002-07
Primary completion
2002-08
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitrofurantoin Unknown 100 mg Oral

Indications

No indication recorded.